Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Sibylla Biotech is a preclinical stage company focused on developing small molecule degraders using a novel mechanism of action to create new therapeutics for unmet medical needs. Their platform…

Sibylla Biotech is a preclinical stage company focused on developing small molecule degraders using a novel mechanism of action to create new therapeutics for unmet medical needs. Their platform…
Stage: Preclinical
Core technology: PPI-FIT folding-interference small-molecule degraders
AI/Platform: Oneiros physics-based protein folding simulations + AI
Last disclosed round: Series A (Oct 4, 2022)
Headquarters: Bresso, Italy
Drug discovery for diseases addressable by targeted protein degradation
2017
Biotechnology
Round reported as a syndicate of eight investors including Indaco Venture Partners and Seroba Life Sciences
“Syndicate includes specialized life-science and VC investors (e.g., V-Bio Ventures, Indaco Venture Partners, Seroba Life Sciences, Claris Ventures, VI Partners, Vertis, CDP Venture Capital, 3B Future Health Fund)”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week